Skip to content
lifestyle.onebyfourstudio.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
R.J. Walker & Co.
Iterion Therapeutics Expands Clinical Development of Tegavivint, a First-in-Class Wnt/β-Catenin Inhibitor, into Colorectal Cancer with First Patient Dosed
March 25, 2026
beHuman Raises $4 Million Seed Round to Expand Equitable, AI-Driven Early Cancer Detection Nationwide
February 10, 2026
←
Previous Page
1
2